CSBR achieved a dramatic turnaround from -$7.3M net loss to $4.7M profit while expanding data licensing capabilities and growing revenue 14% to $56.9M.
This represents a remarkable operational transformation, with the company achieving profitability while simultaneously strengthening its balance sheet and cash position. The removal of previous impairment language and addition of new data licensing revenue streams suggests CSBR has successfully repositioned its business model for sustainable growth.
CSBR delivered exceptional financial improvements across all key metrics, with net income swinging from -$7.3M loss to $4.7M profit and operating cash flow surging from -$6.1M to positive $7.4M. The company strengthened its balance sheet significantly, with stockholders' equity turning positive at $3.8M and cash reserves growing nearly 4x to $3.2M, while total assets expanded 24% to $32.3M. Most notably, CSBR achieved this turnaround while reducing R&D expenses by 28% and cutting capital expenditures in half, demonstrating improved operational efficiency and disciplined capital allocation.
Equity base grew 298.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Cash position surged 278.2% — strong cash generation or capital raise providing significant financial cushion.
Operating cash flow surged 220.4% — exceptional cash generation, highest quality earnings signal.
Net income grew 164.6% — bottom-line growth signals improving overall business health.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Current assets grew 64% — improving short-term liquidity or inventory/receivables build.
Capex reduced 53.5% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
R&D spending cut 28.5% — could signal cost discipline or concerning reduction in innovation investment.
Asset base grew 23.8% — expansion through organic growth, acquisitions, or capital deployment.
Receivables grew 17.9% — monitor days sales outstanding for collection efficiency.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →